|
Jun 21
|
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
|
|
Jun 21
|
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
|
|
Jun 21
|
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
|
|
Jun 20
|
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
|
|
Jun 19
|
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
|
|
Jun 19
|
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
|
|
Jun 19
|
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
|
|
May 10
|
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
|
|
May 10
|
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
|
|
May 9
|
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
|
|
May 9
|
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
|
|
May 9
|
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
|
|
May 9
|
Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
|
|
May 9
|
Zacks.com featured highlights include ResMed, Booz Allen Hamilton and Kontoor Brands
|
|
May 8
|
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
|
|
May 8
|
3 GARP Stocks to Scoop up for Maximum Returns
|
|
May 8
|
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
|
|
May 8
|
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
|
|
May 8
|
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
|
|
May 7
|
ResMed Announces Participation in the RBCCM Global Healthcare Conference
|